VA
Valmark Advisers’s Health Care Select Sector SPDR Fund XLV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.5M | Buy |
122,710
+9,989
| +9% | +$1.35M | 0.23% | 60 |
|
2025
Q1 | $16.5M | Buy |
112,721
+18,933
| +20% | +$2.76M | 0.25% | 56 |
|
2024
Q4 | $12.9M | Buy |
93,788
+9,549
| +11% | +$1.31M | 0.2% | 64 |
|
2024
Q3 | $13M | Buy |
84,239
+6,481
| +8% | +$998K | 0.2% | 59 |
|
2024
Q2 | $11.3M | Buy |
77,758
+6,329
| +9% | +$922K | 0.19% | 59 |
|
2024
Q1 | $10.6M | Buy |
71,429
+15,935
| +29% | +$2.35M | 0.18% | 60 |
|
2023
Q4 | $7.57M | Buy |
55,494
+854
| +2% | +$116K | 0.14% | 66 |
|
2023
Q3 | $7.03M | Sell |
54,640
-787
| -1% | -$101K | 0.15% | 61 |
|
2023
Q2 | $7.36M | Buy |
55,427
+31,017
| +127% | +$4.12M | 0.15% | 59 |
|
2023
Q1 | $3.16M | Sell |
24,410
-1,440
| -6% | -$186K | 0.07% | 101 |
|
2022
Q4 | $3.51M | Buy |
25,850
+2,995
| +13% | +$407K | 0.08% | 89 |
|
2022
Q3 | $2.77M | Sell |
22,855
-11,110
| -33% | -$1.35M | 0.06% | 98 |
|
2022
Q2 | $4.36M | Buy |
33,965
+20,794
| +158% | +$2.67M | 0.08% | 69 |
|
2022
Q1 | $1.8M | Buy |
13,171
+4,418
| +50% | +$605K | 0.03% | 136 |
|
2021
Q4 | $1.23M | Buy |
8,753
+2,180
| +33% | +$307K | 0.02% | 174 |
|
2021
Q3 | $837K | Buy |
6,573
+1,274
| +24% | +$162K | 0.02% | 205 |
|
2021
Q2 | $667K | Buy |
5,299
+1,087
| +26% | +$137K | 0.01% | 242 |
|
2021
Q1 | $492K | Buy |
4,212
+853
| +25% | +$99.6K | 0.01% | 271 |
|
2020
Q4 | $381K | Buy |
3,359
+1,282
| +62% | +$145K | 0.01% | 271 |
|
2020
Q3 | $219K | Buy |
+2,077
| New | +$219K | 0.01% | 276 |
|
2020
Q1 | – | Sell |
-3,521
| Closed | -$359K | – | 245 |
|
2019
Q4 | $359K | Buy |
3,521
+18
| +0.5% | +$1.84K | 0.01% | 172 |
|
2019
Q3 | $316K | Buy |
3,503
+420
| +14% | +$37.9K | 0.01% | 184 |
|
2019
Q2 | $286K | Buy |
3,083
+79
| +3% | +$7.33K | 0.01% | 188 |
|
2019
Q1 | $276K | Buy |
+3,004
| New | +$276K | 0.01% | 188 |
|
2018
Q1 | – | Sell |
-2,441
| Closed | -$202K | – | 200 |
|
2017
Q4 | $202K | Buy |
+2,441
| New | +$202K | ﹤0.01% | 185 |
|